Pages that link to "Q44100320"

The following pages link to The MDR1 polymorphisms at exons 21 and 26 predict steroid weaning in pediatric heart transplant patients (Q44100320):

Displaying 42 items.

• Pharmacogenomics: personalizing pediatric heart transplantation (Q28081200) (← links)
• Predictive genomics of adverse events after cardiac surgery (Q33364022) (← links)
• Phase I dosage finding and pharmacokinetic study of intravenous topotecan and oral erlotinib in adults with refractory solid tumors (Q33412801) (← links)
• Pharmacogenomics of MDR1/ABCB1 gene: the influence on risk and clinical outcome of haematological malignancies (Q34327594) (← links)
• A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas (Q34332525) (← links)
• A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: a report from the Pediatric Brain Tumor Consortium (Q34722457) (← links)
• Association of polymorphisms in pharmacogenetic candidate genes (OPRD1, GAL, ABCB1, OPRM1) with opioid dependence in European population: a case-control study (Q35005588) (← links)
• The current state of, and future prospects for, cardiac transplantation in children (Q35105601) (← links)
• Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs (Q35164664) (← links)
• The MDR1 (ABCB1) gene polymorphism and its clinical implications (Q35817004) (← links)
• Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2. (Q36120816) (← links)
• Does pharmacogenetics have the potential to allow the individualisation of immunosuppressive drug dosing in organ transplantation? (Q36326210) (← links)
• Single nucleotide polymorphisms in human P-glycoprotein: its impact on drug delivery and disposition (Q36349672) (← links)
• Pharmacogenomics and lung transplantation: clinical implications (Q36415330) (← links)
• MDR1 gene polymorphisms and clinical relevance (Q36417994) (← links)
• Heart and lung transplantation in children (Q36525284) (← links)
• ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research. (Q36592129) (← links)
• Clinical pharmacogenetics in pediatric patients (Q36989836) (← links)
• Pharmacogenetics in solid organ transplantation: current status and future directions (Q37218086) (← links)
• Effect of cytokine and pharmacogenomic genetic polymorphisms in transplantation (Q37244838) (← links)
• Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation (Q38047203) (← links)
• Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief. (Q39329852) (← links)
• ABCB1 and SLCO1B3 Gene Polymorphisms and Their Impact on Digoxin Pharmacokinetics in Atrial Fibrillation Patients among the Tunisian Population (Q39531115) (← links)
• The impact of pharmacogenomic factors on acute persistent rejection in adult lung transplant patients (Q40432523) (← links)
• Interleukin-10 production genotype protects against acute persistent rejection after lung transplantation (Q40511543) (← links)
• Identification of budesonide and prednisone as substrates of the intestinal drug efflux pump P-glycoprotein (Q42468905) (← links)
• Tacrolimus Dosing in Pediatric Heart Transplant Patients is Related to CYP3A5 and MDR1 Gene Polymorphisms (Q44402549) (← links)
• Sequential analysis of tacrolimus dosing in adult lung transplant patients with ABCB1 haplotypes (Q44491566) (← links)
• Tacrolimus dosing in adult lung transplant patients is related to cytochrome P4503A5 gene polymorphism (Q44745249) (← links)
• Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia. (Q44826211) (← links)
• Genomic evidence for recent positive selection at the human MDR1 gene locus (Q46509410) (← links)
• Impact of CYP3A5 and MDR1(ABCB1) C3435T polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients (Q46512720) (← links)
• Population pharmacokinetics of gabapentin in healthy Korean subjects with influence of genetic polymorphisms of ABCB1. (Q47822510) (← links)
• MDR-1 gene polymorphisms and clinical course of steroid-responsive nephrotic syndrome in children. (Q51931021) (← links)
• MDR1 haplotypes do not affect the steady-state pharmacokinetics of cyclosporine in renal transplant patients. (Q52949277) (← links)
• MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis. (Q54426860) (← links)
• G2677T and C3435T Genotype and Haplotype Are Associated With HepaticABCB1(MDR1) Expression (Q58869653) (← links)
• Non-HLA Genetic Factors and Their Influence on Heart Transplant Outcomes: A Systematic Review (Q64263291) (← links)
• The effect of MDR1 (ABCB1) polymorphism on the pharmacokinetic of tacrolimus in Turkish renal transplant recipients (Q79781706) (← links)
• P-glycoprotein polymorphism in hypo- and hyper-thyroidism patients (Q81344064) (← links)
• Genetic variability and haplotype profile of MDR1 in Saudi Arabian males (Q87424305) (← links)
• Effects of Comedication and Genetic Factors on the Population Pharmacokinetics of Lamotrigine: A Prospective Analysis in Chinese Patients With Epilepsy (Q92565196) (← links)